Which Companies are Leading in the Life Science Tools Market – Let’s Explore!
- Illumina
- Agilant Technology
- Thermo Fisher Scientific
- Bio-Rad Laboratories
- Becton, Dickinson and Company(BD)
- PerkinElmer
- Merck KAaA
- Waters Corporation
- Bruker Corporation
- Quigen
Life Science Tools Market Overview
According to WHO, collaboration and digitalization have played critical roles in bringing COVID vaccines and therapies to market at an unprecedented rate, saving an estimated 750,000 lives in the United States and Europe alone, and raising demand in the global life sciences tools market.
Life sciences tools refer to various instruments, equipment, reagents, and software used in biological research, diagnostics, and drug discovery. These tools are essential for studying and manipulating biological systems at the molecular, cellular, and organism levels. Examples include DNA sequences, mass spectrometers, microscopes, gene editing tools, and various analytical instruments. Life sciences tools are crucial in advancing and understanding biology, enabling medical discoveries, and facilitating the development of new therapies and diagnostic methods.
The life sciences tools market has experienced growth due to advancements in technology, increased research activities, and rising demand for personalized medicine. Emerging fields like genomics, proteomics, and synthetic biology have driven the demand for sophisticated tools like next-generation sequencing and gene editing technologies. Additionally, the collaboration between academia and industry and government initiatives have fueled innovation, expanding the market for life sciences tools. Overall, the growing biological mechanisms and development of targeted therapies have contributed to the expansion of this market.
Life sciences tools encompass various technologies used to study living organisms. Critical applications include Genomics, Proteomics, Cell Biology, Bioinformatics, and Diagnostic Tools. The continuous advancement of life sciences tools enhances understanding of living systems and contributes to breakthroughs in medicine, agriculture, and environmental science.
Several key life science technologies contribute significantly to the market’s growth. These technologies drive innovation, enhance research capabilities, and play a pivotal role in advancing our understanding of biological processes. Next-generation sequencing (NGS) technologies have revolutionized genomics research by enabling rapid and cost-effective DNA sequencing. This has led to breakthroughs in understanding genetic variations, identifying disease markers, and advancing personalized medicine. CRISPR-Cas9 has transformed molecular biology, allowing precise and targeted editing of genes. This technology has immense potential for understanding gene functions, developing therapeutic interventions, and creating genetically modified organisms for various applications.
Market Growth
The global life science tools market size is forecast to grow at a CAGR of 13%, from USD 156.52 billion in 2025 to USD 470.20 billion by 2034, over the forecast period from 2025 to 2034, as a result of the growing R&D and technology advancements.
Life Science Tools Market Trends
- In January 2025, Takara Bio USA Holdings, Inc. announced the acquisition of Curio Bioscience to combine two innovative spatial biology platforms. The acquisition was made to extend the power of Takara Bio’s NGS solutions and give customers deeper insights into tissue spatial organization and molecular composition.
- In November 2024, Bio-Techne Corporation announced a strategic agreement with Leader Life Sciences. The agreement will allow Leader Life Sciences to distribute Bio-Techne’s product portfolio across the Gulf Cooperation Council (GCC) countries like Bahrain, Oman, Qatar, Saudi Arabia, and UAE.
- In September 2024, Bain Capital Life Sciences (BCLS) announced that it raised $3 billion of total commitments as part of its fourth funding round. The funding was raised to develop transformative medicines, medical devices, diagnostics, and life sciences tools to improve patients’ lives with unmet medical needs.
Current Trends in the Life Science Tools Market
Digital Transformation in Life Sciences
Life sciences companies are increasingly integrating digital tools into their operations, yet they still trail behind other industries in digital maturity. Despite advancements, they struggle with fully leveraging digital capabilities due to misalignment of incentives and the need for agility.
Advancements in Research and Development Tools
The application of digital and analytics tools in research and development (R&D) is yielding significant benefits. These tools are helping to de-risk drug discovery, accelerate clinical trials, and enhance interactions with healthcare providers and patients. However, the full potential of these tools is still being realized.
Growth in Patents and Publications
In 2023, 3.55 million patent applications were filed globally, accounting for a 2.7% increase from 2022. Publications in digital and analytics tools for life sciences have also increased, indicating a growing focus on advancing research capabilities.
Venture Funding and Investments
Venture funding in digital health, which includes investments in life science tools, peaked during the COVID-19 pandemic and remains high. Investments have focused on tools and solutions for commercial applications, research, early development, and regulatory and safety processes. This influx of funding is driving innovation and development in life science tools.
North America Leads Life Sciences Tools Market Growth
- In 2023, Avida Biomed developed high-performance target enrichment workflows with unique features for clinical researchers. The acquired firm employs next-generation sequencing methods to investigate cancer.
U.S. Market Trends
The availability of state-of-the-art research and development facilities and increasing investments boost the market. The number of life science researchers in the U.S. is more than 545,000. The National Institute of Health invested around $26.4 billion as of August 2024 into the life science and healthcare sector.
Canada Market Trends
Canada comprises more than 2,000 life sciences firms, employing more than 220,000 people. In 2023, approximately $82.1 billion was contributed by pharmaceuticals and medical manufacturing to Canada’s GDP. In February 2025, the Government of Canada announced an investment of $6 million for AdMare Bioinnovations to support the establishment of a new life sciences Innovation Center in Vancouver.
Market Data & Statistics
- There are currently more than 10,000 companies in the life sciences platforms and tools sector in the world.
- The increasing number of clinical trials necessitates the use of life sciences tools. About 536,663 clinical trials are registered on the clinicaltrials.gov website as of May 7, 2025.
Latest Announcement by Industry Leaders
Lionel Matthys, Chief Product Officer, Overture Life, commented that Parallel Fluidics’ microfluidic systems such as MV-2 provide advanced care in fertility treatments by precise fluid control and manage sensitive biological samples without wastage. This enables faster, more reliable processes to enhance patient outcomes and drive innovation in reproductive medicine.
Recent Developments
- In 2023, QIAGEN established a strategic agreement with California-based population genomics company Helix to diagnose genetic disorders.
- In February 2025, Bio-Techne announced the launch of an expanded menu of human and mouse RNAscope in situ hybridization probes. The probes can advance spatial biology research and development of next-generation therapeutics and diagnostics.
- In March 2024, bioXcelerate announced the launch of PleioGraph, a new groundbreaking AI tool, to accelerate the process for identifying and developing new drugs. The tool can analyze complex medical data 100x faster to detect biological networks that explain disease risk and inform drug discovery.
Access our exclusive, data-rich dashboard dedicated to the laboratory equipment industry – built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.
Access the Dashboard: https://www.towardshealthcare.com/access-dashboard
Checkout Life Science Tools Market Report Now at: https://www.towardshealthcare.com/checkout/5089
Become a valued research partner with us – https://www.towardshealthcare.com/schedule-meeting
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
Powering Healthcare Leaders with Real-Time Insights: https://www.towardshealthcare.com/healthcare-intelligence-platform
Europe Region – +44 778 256 0738
North America Region – +1 8044 4193 44
APAC Region: +91 9356 9282 04
Visit Our Website: https://www.towardshealthcare.com
Find us on social platforms: LinkedIn | Twitter | Instagram | Medium | Pinterest
About the Author
